These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 33281941)

  • 41. The Impact of SARS-CoV-2 on the Human Immune System and Microbiome.
    Wang C; Zhou X; Wang M; Chen X
    Infect Microbes Dis; 2021 Mar; 3(1):14-21. PubMed ID: 38630064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronavirus disease 2019 and the gut-lung axis.
    Zhou D; Wang Q; Liu H
    Int J Infect Dis; 2021 Dec; 113():300-307. PubMed ID: 34517046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
    Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
    Elife; 2020 Jul; 9():. PubMed ID: 32633718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of the Microbiome in the Pathogenesis of COVID-19.
    De R; Dutta S
    Front Cell Infect Microbiol; 2022; 12():736397. PubMed ID: 35433495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
    Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
    Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roles of the gut microbiota in severe SARS-CoV-2 infection.
    Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
    Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
    Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
    Elife; 2021 Aug; 10():. PubMed ID: 34402426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review.
    Liu TFD; Philippou E; Kolokotroni O; Siakallis G; Rahima K; Constantinou C
    Infection; 2022 Aug; 50(4):815-847. PubMed ID: 34671922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The microbiome in atopic patients and potential modifications in the context of the severe acute respiratory syndrome coronavirus 2 pandemic.
    Lee E; Hong SJ
    Curr Opin Allergy Clin Immunol; 2021 Jun; 21(3):245-251. PubMed ID: 33769313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Gut Microbiome of Children during the COVID-19 Pandemic.
    Bacorn M; Romero-Soto HN; Levy S; Chen Q; Hourigan SK
    Microorganisms; 2022 Dec; 10(12):. PubMed ID: 36557713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas.
    Khreefa Z; Barbier MT; Koksal AR; Love G; Del Valle L
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Baseline gut microbiome features prior to SARS-CoV-2 infection are associated with host symptoms in and post COVID-19.
    Zuo T; Liang G; Huang Z; Cao Z; Bai F; Zhou Y; Wu X; Wu X; Chen YQ; Balati M; Maimaitiyiming M; ; Lan P
    J Med Virol; 2023 Sep; 95(9):e29083. PubMed ID: 37698033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
    Zuo T; Liu Q; Zhang F; Lui GC; Tso EY; Yeoh YK; Chen Z; Boon SS; Chan FK; Chan PK; Ng SC
    Gut; 2021 Feb; 70(2):276-284. PubMed ID: 32690600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection.
    Krasaewes K; Chaiwarith R; Chattipakorn N; Chattipakorn SC
    Life Sci; 2023 Nov; 332():122136. PubMed ID: 37783267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency.
    Sajdel-Sulkowska EM
    Front Pharmacol; 2021; 12():684610. PubMed ID: 34177593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gut microbiota and COVID-19: An intriguing pediatric perspective.
    Valentino MS; Esposito C; Colosimo S; Caprio AM; Puzone S; Guarino S; Marzuillo P; Miraglia Del Giudice E; Di Sessa A
    World J Clin Cases; 2022 Aug; 10(23):8076-8087. PubMed ID: 36159525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The intestinal microbiota predicts COVID-19 severity and fatality regardless of hospital feeding method.
    Bucci V; Ward DV; Bhattarai S; Rojas-Correa M; Purkayastha A; Holler D; Qu MD; Mitchell WG; Yang J; Fountain S; Zeamer A; Forconi CS; Fujimori G; Odwar B; Cawley C; Moormann AM; Wessolossky M; Maldonado-Contreras A
    mSystems; 2023 Aug; 8(4):e0031023. PubMed ID: 37548476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of SARS-CoV2 infection on gut microbiota dysbiosis.
    Xiao Z; Pan M; Li X; Zhao C
    Microbiome Res Rep; 2024; 3(1):7. PubMed ID: 38455085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.